Instil Bio Inc. (TIL)
NASDAQ: TILHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
TIL stock chart
Technical analysisKey statistics
All statistics- Market cap
- $44.49M
- EPS (TTM)
- -$4.43
- Dividend yield
- None
- 52-week range
- 5.67 – 21.98
- Day range
- 6.41 – 6.90
- Volume / Avg
- 54.49K / 12.54K
- Beta
- —
- Shares outstanding
- 6.78M
52-week range
TIL stock today
Shares of Instil Bio (TIL) finished lower on Oct 8 at $6.56, a drop of 4.23% or $0.29 per share, versus the S&P 500's 0.47% decline. Volume was 4.3x the average at 54.49K shares, a sign of unusually heavy trading. Shares are 70.2% below their 52-week high of $21.98, set on Oct 10, 2025 and 15.7% above the 52-week low of $5.67, near the bottom of the past year's range.
TIL is down 40.4% year to date, underperforming the S&P 500 (+13.5%). Over the past 12 months, the stock has lost 68.0%. Instil Bio has posted a net loss over the last twelve months (EPS of -$4.43), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Instil Bio
Company profileInstil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Bronson Crouch
- Headquarters
- Dallas, TX
- Employees
- 17
- IPO year
- 2021
- Website
- instilbio.com
Analyst forecast
ForecastConsensus (1 analysts)
none
Avg. price target
$7.00+6.71%
- Strong buy 0
- Buy 0
- Hold 1
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Instil Bio peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HOWLWerewolf Therapeutics Inc. | 0.91 | -1.10% | $44.23M | vs TIL |
| TVGNTevogen Inc. | 7.06 | +8.78% | $45.97M | vs TIL |
| GRCEGrace Therapeutics Inc. | 2.04 | -2.86% | $42.91M | vs TIL |
| CELUCelularity Inc. Class A | 1.46 | -0.68% | $47.38M | vs TIL |
| ELTXElicio Therapeutics Inc. | 1.81 | -2.16% | $47.57M | vs TIL |
| VERUVeru Inc. | 2.42 | -1.63% | $41.26M | vs TIL |
| DWTXDogwood Therapeutics Inc. | 1.41 | -1.40% | $47.93M | vs TIL |
| IMAImageneBio Inc. | 4.26 | -7.59% | $48.45M | vs TIL |
Indexes, lists and sector
Appears in lists
Instil Bio stock FAQ
What is Instil Bio's stock price today?
TIL last traded at $6.56 as of Oct 8, 4:00 PM EDT, down 4.23% on the day. Prices are delayed at least 15 minutes.
Does Instil Bio pay a dividend?
No. Instil Bio does not currently pay a regular cash dividend.
Who is Instil Bio's CEO?
Mr. Bronson Crouch is the chief executive officer of Instil Bio Inc., which has about 17 employees.
Has TIL ever split its stock?
Yes. The most recent TIL stock split was a 1-for-20 split on Dec 8, 2023.
What is the TIL 52-week high?
The 52-week high for TIL is $21.98 and the 52-week low is $5.67. The stock is currently 70.2% below its high.